UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT FILED PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED): JULY 6, 2004
ZONAGEN, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 0-21198 76-0233274
(STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER IDENTIFICATION NO.)
INCORPORATION OR ORGANIZATION)
2408 TIMBERLOCH PLACE, SUITE B-1
THE WOODLANDS, TEXAS 77380
(ADDRESS OF PRINCIPAL
EXECUTIVE OFFICES
AND ZIP CODE)
(281) 719-3400
(REGISTRANT'S TELEPHONE NUMBER,
INCLUDING AREA CODE)
ITEM 5. OTHER INFORMATION
On July 6, 2004, Zonagen, Inc. (the "Company") announced in a press
release that Nasdaq approved its application for its stock to trade on the
Nasdaq SmallCap Market. Zonagen's stock will transfer from the Nasdaq National
Market to the Nasdaq SmallCap Market and begin trading on the Nasdaq SmallCap
Market at the open of business on July 8, 2004.
A copy of the Company's press release is attached hereto as Exhibit
99.1. The press release is incorporated by reference herein and the foregoing
description of the press release is qualified in its entirety by reference to
the attached exhibit.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
c. Exhibits
Exhibit
Number Description
------- -----------
99.1 Press Release dated July 6, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ZONAGEN, INC.
Date: July 7, 2004.
By: /s/ Louis Ploth, Jr.
-------------------------------------------
Louis Ploth, Jr.
Vice President, Business Development and
Chief Financial Officer
EXHIBIT INDEX
Exhibit
Number Description
------- ------------
99.1 Press Release dated July 6, 2004.